Lipoprotein components and risk of congestive heart failure in 84 740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)

European Journal of Heart Failure

Volumn 11, Issue 11, 2009, Pages 1036-1042

  Holme, Ingar ^a   Aastveit, Are H ^b   Hammar, Niklas ^c,d   Jungner, Ingmar ^c   Walldius, Göran ^c,e  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c KAROLINSKA INSTITUTE   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

Author keywords

Apolipoprotein A 1; Apolipoprotein B; Heart failure; Inflammation; Lipoproteins; Oxidation

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; GLUCOSE; HAPTOGLOBIN; LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DISEASE COURSE; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BLOOD GLUCOSE; FEMALE; HAPTOGLOBINS; HEART FAILURE; HUMANS; LONGITUDINAL STUDIES; MALE; MYOCARDIAL INFARCTION; RISK FACTORS; SEX FACTORS; SINGLE-BLIND METHOD; SWEDEN; TREATMENT OUTCOME; TRIGLYCERIDES; URIC ACID;

EID: 70350689523     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp129     Document Type: Article

References (30)

1. Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 2007;49:1943-1950.
2. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PWF, D'Agostino RB. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003;107:1486-1491. (Pubitemid 36378485)
3. Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaugan DE, Satterfield S, Newman AB, Goodpaster B, Bauer DC, Holvoet P, Harris TB, de Rekeneire N, Rubin S, Ding J, Kritchevsky SB. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 2006;47:1595-1602.
4. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991;121: 951-957.
5. Wilhelmsen L, Rosengren A, Eriksson H, Lappas G. Heart failure in the general population of men-morbidity, risk factors and prognosis. J Int Med 2001;249: 253-261. (Pubitemid 32417788)
6. Bahrami H, Bluemke DA, Kronmal R, Bertoni AG, Lloyd-Jones DM, Shahar E, Szklo M, Lima JAC. Novel metabolic risk factors for incident heart failure and their relationship with obesity. The MESA (Multi-Ethnic Study of Atherosclerosis) Study. J Am Coll Cardiol 2008;51:1775-1783.
7. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, Gardin JM, Rutledge JE, Boineau RC. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000;35:1628-1637.
8. Ingelsson E, Arnlöv J, Sundström J, Zethelius B, Vessby B, Lind L. Novel metabolic risk factors for heart failure. J Am Coll Cardiol 2005;46:2054-2060.
9. Dhingra R, Sesso HD, Kenchaiah S, Gaziano JM. Differential effects of lipids on the risk of heart failure and coronary heart disease: the Physicianś Health Study. Am Heart J 2008;155:869-875.
10. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, on behalf of the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364: 937-952.
11. Holme I, Aastveit AH, Jungner I, Walldius G. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Int Med 2008;264:30-38.
12. Kastelein JJP, Van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM, for the TNT and IDEAL Study Groups. Lipids, apoli-poproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation 2008;117:3002-3009.
13. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Int Med 2009; doi:10.1111/j.1365-2796.2009.02133x.
14. Walldius G, Jungner I, Kolar W, Holme I, Steiner E. High cholesterol and triglycer-ide values in Swedish males and females: increased risk of fatal myocardial infarction: first report from the AMORIS (Apolipoprotein related MOrtality RISk) study. Blood Pressure 1992;1(Suppl. 4):35-42.
15. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipopro-tein B, low apolipoprotein A-1, and improvement in the prediction of fatal myo-cardial infarction (AMORIS study): a prospective study. Lancet 2001;358: 2026-2033.
16. Walldius G, Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence. J Int Med 2006;259:493-519.
17. Walldius G, Aastveit AH, Jungner I. Stroke mortality and the apoB/apoA-1 ratio: results of the AMORIS prospective study. J Int Med 2006;259:259-266.
18. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MORtality RISk study (AMORIS). J Int Med 2009;265:275-287.
19. Kümler T, Gislason GH, Kirk V, Bay M, Nielsen OW, Køber L, Torp-Pedersen C. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail 2008;10:658-660.
20. Ingelsson E, Arnlöw J, Sundström J, Lind L. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 2005;7:787-791.
21. Jungner I, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-1 in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females. Int J Clin Lab Res 1992;31:247-255.
22. Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A-1 values in 147 576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials. Clin Chem 1998;44:1641-1649.
23. Marcovina SM, Albers JJ, Henderson LO, Hannon WH. International Federation of Clinical Chemistry Standardization Project for Measurements of Apolipoproteins A-1 and B. III. Comparability of apolipoprotein A-1 values by use of International Reference Material. Clin Chem 1993;39:773-781.
24. Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson LO, Hannon WH. International Federation of Clinical Chemistry Standardization Project for Measurements of Apolipoproteins A-1 and B. IV. Comparability of apolipoproteins B values by use of International Reference Material. Clin Chem 1994;40:586-592.
25. Talmud PJ, Hawe E, Miller GJ, Humphries SE. Nonfasting apolipoprotein B and tri-glyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol 2002;22:1918-1923.
26. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-456.
27. Lundberg M, Fredlund P, Hallqvist J, Dederichsen F. A SAS program calculating three measures of interaction with confidence intervals. Epidemiology 1996;7: 655-656.
28. Rothmann KJ. The estimation of synergism and antagonism. Am J Epidemiol 1976; 103:506-511.
29. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Haptoglobin and risk of myocardial infarction, stroke and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Ann Med 2009; 41:522-532.
30. Holzmann MJ, Jungner I, Walldius G, Ivert T, Nordqvist T, Ostergren J, Hammar N. Apolipoproteins B and A-I, standard lipid measures and incidence of myocardial infarction in men and women, with or without chronic kidney disease Study IV in Thesis for doctorial degree (PhD). Karolinska Institutet 2008. By Holzmann M: renal insufficiency, mortality and myocardial infarction.